METABOLIC SYNDROME: HYPERTENSION, DIABETES AND OBESITY: A MINI-REVIEW
This work aims to present the relation to metabolic syndrome with cardiovascular diseases and shows parameters given by ATP III and NHANES III studies. The principal results of these studies were presented in this work. The actual tendency about hypertension, diabetes and obesity are also showed. The conclusion indicates the use of these parameters to obtain quality of life.
Alexander CM, Landsman PB, Teutsch SM, Haffner SM. 2003.NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart diseaseamong NHANES III participants age 50 years and older. Diabetes,52(5),1210-1214.
Arboix A. 2015.Cardiovascular risk factors for acute stroke: Risk profiles in the different subtypes of ischemic stroke. World J Clin Cases,3(5),418-429.
Bray G, Heisel W, Afshin A, Jensen M, Dietz Wet al., 2018.The science of obesity management: An endocrine society scientific statement. Endocrine Reviews,39(2), 79-132.
Chen R, Ovbiagele B, Feng W. 2016.Diabetes and stroke: Epidemiology, pathophysiology, pharmaceuticals and outcomes. Am J Med Sci,351(4),380-396.
Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR. 2003.The metabolic syndrome: Prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination survey, 1988-1994. Arch Intern Med,163(4),427-436.
Pelikanova T. 2003 The metabolic syndrome. Vnitr Lek,49(12), 900-906.Piłaciński S, Zozulińska-Ziółkiewicz DA.2014.Influence of lifestyle on the course of type 1 diabetes mellitus.Arch Med Sci,10(1), 124-134.
Rosembaum P. 2003.Uma atualização em risco cardiovascular da síndrome metabólica.Arq Bras Endocrinol Metab,47(3), 220-227.
Tun NN, Arunagirinathan G, Munshi SK,Pappachan JM. 2011.Diabetes mellitus and stroke: a clinical update. World J Diabetes,8(6),235-248.